Results 81 to 90 of about 25,714 (212)

Marburg virus pathogenesis – differences and similarities in humans and animal models

Virology Journal, 2019
Marburg virus (MARV) is a highly pathogenic virus associated with severe disease and mortality rates as high as 90%. Outbreaks of MARV are sporadic, deadly, and often characterized by a lack of resources and facilities to diagnose and treat patients ...
Kyle Shifflett, Andrea Marzi
doaj   +1 more source

Marburg virus disease: a brief updated overview

International Journal of Research in Medical Sciences, 2023
The Marburg virus disease made headlines when Tanzania declared an outbreak on the 23rd of March 2023. Five deaths and three further cases were identified at the time of the announcement. Symptoms of Marburg virus can include fever, headache, muscle aches, vomiting, diarrhoea, and bleeding from various parts of the body, hence the similarity to Ebola ...
Ahmed Elhamalawy, Rahaf Elgonaid
openaire   +1 more source

Community Awareness, Knowledge, Attitudes, and Perceptions Toward Viral Disease Outbreaks in Dar es Salaam, Tanzania

Public Health Challenges, Volume 5, Issue 2, June 2026.
High awareness of viral outbreaks in Dar es Salaam coexists with critical knowledge gaps, stigma, and vaccine hesitancy driven by trust and safety concerns. Targeted myth correction, anti‐stigma initiatives, and strategic digital health communication are essential to strengthen community preparedness and outbreak response.
Mohammed Elmogiera Fadlallh Elsayed, Emmanuel J. Magandi, Sima Rugarabamu   +2 more
wiley   +1 more source

Can Marburg virus be sexually transmitted?

Health Science Reports
Background and Aim Marburg virus (MARV) is a highly virulent virus of animal origin and the cause of a lethal infection (known as Marburg virus disease [MVD]) with a case‐fatality ratio ranging from 24% to 90%.
Hassan Karami, Arash Letafati, Somayeh Sadat Hosseini Fakhr   +2 more
doaj   +1 more source

An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting. [PDF]

, 2005
BACKGROUND: Polysaccharide pneumococcal vaccination for older adults is being introduced in developed country settings. Evidence of protection by this vaccine against pneumococcal pneumonia, or confirmation that illness and death from bacteraemia are ...
Cutts, Felicity T, Hall, Andrew J, Mangtani, Punam, Roberts, Jennifer A   +3 more
core   +1 more source

Marburg virus disease: In a nutshell

Journal of Biomedical Sciences, 2023
No abstract available.
openaire   +1 more source

Carbohydrate‐Based Drug Discovery: Synthetic Strategies and Clinical Applications

Israel Journal of Chemistry, Volume 66, Issue 3, May 2026.
The picture depicts the molecules discussed in the review. On the left side, the general scaffold of sugars is shown. Next to it are four carbohydrate‐based molecules, including remdesivir, islatravir, empagliflozin, and Globo‐H. Remdesivir and islatravir contain a substituted ribose ring attached to a modified nucleobase.
Stephan Scheeff, Jemma Arakelyan, Billy Wai‐Lung Ng   +2 more
wiley   +1 more source

In silico exploration of deep-sea fungal metabolites as inhibitor of Ebola and Marburg VP35 and VP40.

PLoS ONE
VP30 and VP40 proteins of Ebola and Marburg viruses have been recognized as potential targets for antiviral drug development due to their essential roles in the viral lifecycle.
Abdullah R Alanzi, Mohammed F Alajmi, Mohammed S Al-Dosari, Mohammad K Parvez, Moneerah J Alqahtani   +4 more
doaj   +1 more source

Postoperative Pain After Endodontic Treatment in HIV‐Positive Patients Under HAART: A Prospective Observational Cohort Study

International Endodontic Journal, Volume 59, Issue 5, Page 788-793, May 2026.
ABSTRACT Aim To compare post‐operative pain following root canal treatment (RCT) in HIV‐positive patients receiving highly active antiretroviral therapy (HAART) and HIV‐negative patients and to assess the influence of systemic condition on endodontic pain.
Marcos Felipe Iparraguirre Nuñovero, Marco Antonio Hungaro Duarte, Luciana Reis Azevedo Alanis, Bruno Cavalini Cavenago, Ulisses Xavier da Silva Neto, Everdan Carneiro   +5 more
wiley   +1 more source

Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruse.

PLoS Pathogens
Viral haemorrhagic fevers (VHF) pose a significant threat to human health. In recent years, VHF outbreaks caused by Ebola, Marburg and Lassa viruses have caused substantial morbidity and mortality in West and Central Africa.
Amy Flaxman, Sarah Sebastian, Sofia Appelberg, Kuan M Cha, Marta Ulaszewska, Jyothi Purushotham, Ciaran Gilbride, Hannah Sharpe, Alexandra J Spencer, Sagida Bibi, Daniel Wright, Isabel Schmidt, Stuart Dowall, Linda Easterbrook, Stephen Findlay-Wilson, Sarah Gilbert, Ali Mirazimi, Teresa Lambe   +17 more
doaj   +1 more source